Informa PLC

Director's Dealing • Dec 18, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3270X

Informa PLC

18 December 2019

Informa LEI: 5493006VM2LKUPSEDU20

Informa PLC Press Release

18 December 2019

Director/PDMR Shareholding

London: Informa PLC ("the Company") has been notified that Stephen A. Carter, Group Chief Executive, exercised the following awards granted under the Company's 2014 Long-Term Incentive Plan (LTIP) and 2014 Deferred Share Bonus Plan (DSBP) on 16 December 2019:

Date of Award	Share Plan	Number of options and related dividend shares	Total exercise cost
8 September 2014	LTIP	305,297	£305.29
12 February 2015	LTIP	150,000	£150.00
17 March 2016	DSBP	6,735	£1.00

Stephen A. Carter sold all ordinary shares at a price of 822.20 pence per share.

The exercise took place outside of a trading venue and the sale took place in London.

Following the sale, Mr Carter retains vested and unvested options and related dividend shares in respect of more than 1.6 million shares in Informa.

This notification is made in accordance with the requirements of Article 19.3 of the Market Abuse Regulations.

Enquiries
Informa PLC Rupert Hopley, Group Company Secretary Richard Menzies-Gow, Director of IR & Comms	+44 (0)20 7017 5587 +44 (0)20 3377 3445
Teneo Strategy Tim Burt / Zoë Watt	+44 (0)20 7240 2486

Notes to Editors

Informa PLC

Informa is a leading international Exhibitions, Events, Information Services and Scholarly Publishing Group with annual revenues approaching £3 billion. It helps commercial, professional and academic communities work smarter and make better decisions faster, through specialist content and intelligence, and opportunities to connect and learn. For more information, please visit www.informa.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHZMMMZGRVGLZM